These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39213797)

  • 1. Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors.
    Abdelaal HI; Mohamed AR; Abo-Ashour MF; Giovannuzzi S; Fahim SH; Abdel-Aziz HA; Supuran CT; Abou-Seri SM
    Bioorg Chem; 2024 Nov; 152():107759. PubMed ID: 39213797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.
    Chandra KM; Goud NS; Arifuddin M; Alvala M; Alvala R; Angeli A; Supuran CT
    Bioorg Med Chem Lett; 2021 May; 39():127877. PubMed ID: 33640442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
    Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
    Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms.
    Eldehna WM; Taghour MS; Al-Warhi T; Nocentini A; Elbadawi MM; Mahdy HA; Abdelrahman MA; Alotaibi OJ; Aljaeed N; Elimam DM; Afarinkia K; Abdel-Aziz HA; Supuran CT
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):531-541. PubMed ID: 34991416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
    Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
    Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
    Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
    Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.
    Narella SG; Shaik MG; Mohammed A; Alvala M; Angeli A; Supuran CT
    Bioorg Chem; 2019 Jun; 87():765-772. PubMed ID: 30974299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
    Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
    Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,3-Diaryl Triazenes Incorporating Disulfonamides Show Both Antiproliferative Activity and Effective Inhibition of Tumor-associated Carbonic Anhydrases IX and XII.
    Lolak N; Akocak S; Petreni A; Budak Y; Bozgeyik E; Gurdere MB; Ceylan M; Supuran CT
    Anticancer Agents Med Chem; 2024; 24(10):755-763. PubMed ID: 38362678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.
    Abdelrahman MA; Ibrahim HS; Nocentini A; Eldehna WM; Bonardi A; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2021 Jan; 209():112897. PubMed ID: 33038795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
    De Luca L; Mancuso F; Ferro S; Buemi MR; Angeli A; Del Prete S; Capasso C; Supuran CT; Gitto R
    Eur J Med Chem; 2018 Jan; 143():276-282. PubMed ID: 29197732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Sridhar Goud N; Argulwar OS; Soman J; Angeli A; Alvala M; Arifuddin M; Supuran CT
    Bioorg Chem; 2020 Nov; 104():104272. PubMed ID: 32961467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Bonardi A; Falsini M; Catarzi D; Varano F; Di Cesare Mannelli L; Tenci B; Ghelardini C; Angeli A; Supuran CT; Colotta V
    Eur J Med Chem; 2018 Feb; 146():47-59. PubMed ID: 29407972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities.
    An R; Lin B; Zhao S; Cao C; Wang Y; Cheng X; Liu Y; Guo M; Xu H; Wang Y; Hou Z; Guo C
    Bioorg Chem; 2020 Nov; 104():104347. PubMed ID: 33142414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and in vitro evaluation of novel thiazole-coumarin hybrids as selective and potent human carbonic anhydrase IX and XII inhibitors.
    Singh P; Nerella SG; Swain B; Angeli A; Ullah Q; Supuran CT; Arifuddin M
    Int J Biol Macromol; 2024 May; 268(Pt 1):131548. PubMed ID: 38642682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
    Chandak N; Ceruso M; Supuran CT; Sharma PK
    Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Angeli A; Argulwar OS; Tiwari PL; Arifuddin M; Supuran CT
    Bioorg Chem; 2020 May; 98():103739. PubMed ID: 32193032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
    Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.